Fundz

Rosemont Pharmaceuticals Appoints Alok Sonig as Chief Executive Officer

PRIVATEDec 16, 2025

Position

Chief Executive Officer

Company

Rosemont Pharmaceuticals

Alok Sonig
ManufacturingBiotechnologyHealth CarePharmaceutical

Description

Rosemont Pharmaceuticals has appointed Alok Sonig as its new Chief Executive Officer as part of its expansion into the USA, Canadian, and European pharmaceutical markets. Mr. Sonig brings 30 years of experience in the industry, previously serving as executive vice-president at Baxter International.

Quick answer

Rosemont Pharmaceuticals Appoints Alok Sonig as Chief Executive Officer (December 16, 2025).

Who is the new Chief Executive Officer at Rosemont Pharmaceuticals?
Rosemont Pharmaceuticals named Alok Sonig Chief Executive Officer, announced December 16, 2025.
What did Rosemont Pharmaceuticals announce on December 16, 2025?
Rosemont Pharmaceuticals has appointed Alok Sonig as its new Chief Executive Officer as part of its expansion into the USA, Canadian, and European pharmaceutical markets. Mr. Sonig brings 30 years of experience in the industry, previously serving as executive vice-president at Baxter International.
What does Rosemont Pharmaceuticals do?
Rosemont Pharmaceuticals is a UK-based manufacturer specializing in liquid medicines.
Which similar companies made leadership changes around the same time?
Jubilant Therapeutics (December 2, 2025), Assertio Holdings (November 21, 2025), Granules India (November 14, 2025) and Altanine (January 28, 2026) also announced leadership changes within 45 days of Rosemont Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rosemont Pharmaceuticals, and when

A new leader at Rosemont Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rosemont Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rosemont Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rosemont Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rosemont Pharmaceuticals

About

Rosemont Pharmaceuticals is a UK-based manufacturer specializing in liquid medicines. The company focuses on expanding its reach in the pharmaceutical markets of the USA, Canada, and Europe. It leverages expertise in generic medicine and biosimilars to drive growth. Rosemont aims to provide high-quality pharmaceutical solutions to meet patient needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rosemont Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rosemont Pharmaceuticals's next move

Learn about Strategic plan

Rosemont Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.